Please login to the form below

Not currently logged in

RSV bivalent prefusion F

This page shows the latest RSV bivalent prefusion F news and features for those working in and with pharma, biotech and healthcare.

Pfizer starts RSV trial ahead of winter season

Pfizer starts RSV trial ahead of winter season

Last week, Pfizer announced the start of a phase 3 trial for its new RSV bivalent prefusion F (RSVpreF) subunit vaccine in adults aged 60 or over. ... RSV is a common and pervasive seasonal respiratory illness that is highly contagious.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story